Encompass Health (EHC) Liabilities and Shareholders Equity (2009 - 2026)

Encompass Health has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $7.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.12% year-over-year to $7.3 billion; the trailing twelve-month figure through Mar 2026 stood at $28.1 billion (up 7.81% YoY), and the FY2025 full-year result was $7.1 billion, up 8.49% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $7.3 billion, up from $7.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $7.3 billion in Q1 2026, with the low at $5.5 billion in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $6.4 billion across 5 years, with a median of $6.5 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 18.53% — and 2026, when it grew 10.12%.
• Encompass Health's Liabilities and Shareholders Equity stood at $5.6 billion in 2022, then rose by 8.27% to $6.1 billion in 2023, then grew by 7.08% to $6.5 billion in 2024, then grew by 8.49% to $7.1 billion in 2025, then advanced by 3.15% to $7.3 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $7.3 billion (Q1 2026), $7.1 billion (Q4 2025), and $6.9 billion (Q3 2025), per Business Quant data.